Underrecognition of cognitive impairment in assisted living facilities

被引:52
作者
Magsi, H [1 ]
Malloy, T [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Family Med, Omaha, NE 68198 USA
关键词
dementia; assisted living; cognitive impairment;
D O I
10.1111/j.1532-5415.2005.53117.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To determine the prevalence of cognitive impairment (CI), dementia diagnosis and treatment, assistance with medications, and surrogate decision-makers for residents of assisted living facilities (ALFs). DESIGN: Cross-sectional study. SETTING: Seven ALFs in Omaha, Nebraska, and the surrounding area. None of the ALFs in this study were designated "Alzheimer's" or "dementia" facilities. PARTICIPANTS: Four hundred seven of 455 ALF residents were solicited, and 230 consented. The average age +/- standard deviation of participants was 83.3+/-8.3. MEASUREMENTS: ALF residents were examined using the Mini-Mental State Examination (MMSE), and their medical charts were reviewed. RESULTS: Fifty-eight percent of ALF residents had CI according to the MMSE. Of those with CI, 63% had no diagnosis of dementia, 75% were not treated for dementia, 41% with a documented diagnosis of dementia were not treated for dementia, 22% self-administered an average of 5.4+/-3.4 medications daily, and 11% had surrogate decision makers. CONCLUSION: More than half of ALF residents in this study had CI and a significant percentage was undiagnosed. Even when diagnosed as dementia, CI is significantly undertreated in this setting. These deficits must be addressed to promote quality of care and the need for specialized attention.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 28 条
[1]  
*ADV PAN ALZH DIS, 1996, NIH PUBL
[2]  
[Anonymous], NATL STUDY ASSISTED
[3]   EPIDEMIOLOGY OF ALZHEIMERS-DISEASE [J].
BRETELER, MMB ;
CLAUS, JJ ;
VANDUIJN, CM ;
LAUNER, LJ ;
HOFMAN, A .
EPIDEMIOLOGIC REVIEWS, 1992, 14 :59-82
[4]   The effects of donepezil in Alzheimer's disease -: Results from a multinational trial [J].
Burns, A ;
Rossor, M ;
Hecker, J ;
Gauthier, S ;
Petit, H ;
Möller, HJ ;
Rogers, SL ;
Friedhoff, LT .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (03) :237-244
[5]  
Chandler J D, 1988, J Geriatr Psychiatry Neurol, V1, P71, DOI 10.1177/089198878800100203
[6]   POPULATION-BASED NORMS FOR THE MINI-MENTAL-STATE-EXAMINATION BY AGE AND EDUCATIONAL-LEVEL [J].
CRUM, RM ;
ANTHONY, JC ;
BASSETT, SS ;
FOLSTEIN, MF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (18) :2386-2391
[7]   Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities [J].
Cummings, JL ;
Vinters, HV ;
Cole, GM ;
Khachaturian, ZS .
NEUROLOGY, 1998, 51 (01) :S2-S17
[8]   MINI-MENTAL-STATE-EXAMINATION - NORMS, NORMALS, AND NUMBERS [J].
CUMMINGS, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (18) :2420-2421
[9]   Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease [J].
Doody, RS ;
Geldmacher, DS ;
Gordon, B ;
Perdomo, CA ;
Pratt, RD .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :427-433
[10]   Cognitive function and the costs of Alzheimer disease - An exploratory study [J].
Ernst, RL ;
Hay, JW ;
Fenn, C ;
Tinklenberg, J ;
Yesavage, JA .
ARCHIVES OF NEUROLOGY, 1997, 54 (06) :687-693